Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 3569
Gene Symbol: IL6
IL6
0.010 AlteredExpression disease BEFREE IL-6R was expressed in all patients with AML and AMLL, whereas only half of ALL patients expressed low levels of IL-6R as compared with those with AML and AMLL. 7919380 1994
Entrez Id: 3572
Gene Symbol: IL6ST
IL6ST
0.010 AlteredExpression disease BEFREE However, gp130 was ubiquitously expressed in all the leukemia patients, and there was no significant difference in gp130 expression among AML, ALL, and AMLL. 7919380 1994
Entrez Id: 3716
Gene Symbol: JAK1
JAK1
0.010 Biomarker disease BEFREE Philadelphia Chromosome-like Mixed-Phenotype Acute Leukemia Demonstrating P2RY8-CRLF2 Fusion and JAK1 Mutation. 29140408 2017
Entrez Id: 7994
Gene Symbol: KAT6A
KAT6A
0.020 GeneticVariation disease BEFREE Fusion of the MOZ and TIF2 genes by an inv (8) (p11q13) translocation has been identified in patients with acute mixed-lineage leukemia. 17697320 2007
Entrez Id: 7994
Gene Symbol: KAT6A
KAT6A
0.020 GeneticVariation disease BEFREE Acute mixed lineage leukemia with an inv(8)(p11q13) resulting in fusion of the genes for MOZ and TIF2. 9731070 1998
Entrez Id: 3815
Gene Symbol: KIT
KIT
0.010 Biomarker disease BEFREE Although the specificity of CD117 in this study is not as high as CD14 and CD64, markers concomitantly used in this this study and in the WHO classification, based on the results of other researches (i.e. the specificity of CD117 for AML was 100% in one study) and due to the fact that its specificity for AML in this study is relatively high, we recommend the use CD117 in assigning a myeloid lineage in MPAL. 28625325 2017
Entrez Id: 4297
Gene Symbol: KMT2A
KMT2A
0.350 GeneticVariation disease BEFREE Acute mixed-lineage leukemia t(4;11)(q21;q23) generates an MLL-AF4 fusion product. 7689231 1993
Entrez Id: 4297
Gene Symbol: KMT2A
KMT2A
0.350 FusionGene disease ORPHANET Mixed-Phenotype Acute Leukemia: Diagnostic Criteria and Pitfalls. 29072953 2017
Entrez Id: 4297
Gene Symbol: KMT2A
KMT2A
0.350 GeneticVariation disease BEFREE MPAL with t(9;22) and MLL rearrangement have been separated. 20844566 2010
Entrez Id: 4297
Gene Symbol: KMT2A
KMT2A
0.350 AlteredExpression disease BEFREE In addition, evaluation of BCR/ABL1 and MLL rearrangements in patients should be part of standard work-up in MPAL. 30019150 2018
Entrez Id: 4297
Gene Symbol: KMT2A
KMT2A
0.350 FusionGene disease ORPHANET Acute leukemias of ambiguous origin. 26276768 2015
Entrez Id: 4297
Gene Symbol: KMT2A
KMT2A
0.350 FusionGene disease ORPHANET The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. 27069254 2016
Entrez Id: 4297
Gene Symbol: KMT2A
KMT2A
0.350 Biomarker disease BEFREE Specific subsets of MPAL are defined by chromosomal anomalies such as the t(9;22) Philadelphia chromosome BCR-ABL1 or involvement of the MLL gene on chromosome 11q23. 22372202 2012
Entrez Id: 4297
Gene Symbol: KMT2A
KMT2A
0.350 GeneticVariation disease BEFREE From a clinical practice standpoint, this case illustrates the importance of detection of MLL rearrangement due to its prognostic implication and the effectiveness of flow cytometry immunophenotyping in diagnosing MPAL and monitoring minimal residual disease. 20299091 2010
Entrez Id: 10128
Gene Symbol: LRPPRC
LRPPRC
0.010 AlteredExpression disease BEFREE However, gp130 was ubiquitously expressed in all the leukemia patients, and there was no significant difference in gp130 expression among AML, ALL, and AMLL. 7919380 1994
Entrez Id: 4298
Gene Symbol: MLLT1
MLLT1
0.010 GeneticVariation disease BEFREE Mixed phenotype acute leukemia with t(11;19)(q23;p13.3)/ MLL-MLLT1(ENL), B/T-lymphoid type: A first case report. 20513125 2010
Entrez Id: 8028
Gene Symbol: MLLT10
MLLT10
0.020 Biomarker disease BEFREE To the best of our knowledge, this is the first reported MLL-MLLT10 rearranged case presenting as MPAL in an infant. 20299091 2010
Entrez Id: 8028
Gene Symbol: MLLT10
MLLT10
0.020 Biomarker disease BEFREE Although rare, CALM/AF10 is a chromosomal rearrangement found in immature T-cell acute lymphoblastic leukemia (T-ALL), acute myeloid leukemia, and mixed phenotype acute leukemia of T/myeloid lineages with poor prognosis. 31141090 2019
Entrez Id: 4524
Gene Symbol: MTHFR
MTHFR
0.010 GeneticVariation disease BEFREE Impairment in function of GST and MTHFR enzymes found in our patient may have contributed to the development of secondary mixed phenotype acute leukemia, although precise mechanism remains elusive. 24276031 2014
Entrez Id: 10499
Gene Symbol: NCOA2
NCOA2
0.020 GeneticVariation disease BEFREE Acute mixed lineage leukemia with an inv(8)(p11q13) resulting in fusion of the genes for MOZ and TIF2. 9731070 1998
Entrez Id: 10499
Gene Symbol: NCOA2
NCOA2
0.020 GeneticVariation disease BEFREE Fusion of the MOZ and TIF2 genes by an inv (8) (p11q13) translocation has been identified in patients with acute mixed-lineage leukemia. 17697320 2007
Entrez Id: 4827
Gene Symbol: NM
NM
0.010 AlteredExpression disease BEFREE However, gp130 was ubiquitously expressed in all the leukemia patients, and there was no significant difference in gp130 expression among AML, ALL, and AMLL. 7919380 1994
Entrez Id: 4893
Gene Symbol: NRAS
NRAS
0.010 GeneticVariation disease BEFREE ATM was also mutated in a T-myeloid MPAL case with additional loss at 7q21.2-q36.3 and mutation of NRAS, two alterations common in myeloid disorders. 30578714 2019
Entrez Id: 611
Gene Symbol: OPN1SW
OPN1SW
0.010 Biomarker disease BEFREE Taken together, our data suggest that BTG1 deletions might play a role in leukemogenesis of BCP-ALL as well as of BCR-ABL1-positive MPAL and CML-BC (B-lineage). 24998463 2014
Entrez Id: 286530
Gene Symbol: P2RY8
P2RY8
0.010 Biomarker disease BEFREE Philadelphia Chromosome-like Mixed-Phenotype Acute Leukemia Demonstrating P2RY8-CRLF2 Fusion and JAK1 Mutation. 29140408 2017